BAXTER HEALTHCARE CORP

Overview

BAXTER HEALTHCARE CORP is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering CYCLOPHOSPHAMIDE, USP/EP; IFOSFAMIDE USP/EP; MESNA, USP/EP DRUG SUBSTANCE.

API / Drug Master Files

BAXTER HEALTHCARE CORP holds 3 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MESNA, USP/EP DRUG SUBSTANCEActive2011-09-08
• CYCLOPHOSPHAMIDE, USP/EPActive1979-06-11
• IFOSFAMIDE USP/EPActive1979-04-24
• MURINE MONOCLONAL ANTIBODIES (ANTI-CD8/CD4) TO HUMAN T-CELLSInactive2005-08-23
• ANTI-PROTEIN C AFFINITY MATRIXInactive1990-12-21
• FACILITIES IN MORTON GROVE, IL AND BRIDGEPORT, NJInactive1988-07-12

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BAXTER HEALTHCARE CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.